Jagsonpal Pharmaceuticals Overview
- Year Founded
-
1978
- Status
-
Public
- Employees
-
1,305
- Stock Symbol
-
507789
- Investments
-
5
- Share Price
-
$2.30
- (As of Friday Closing)
Jagsonpal Pharmaceuticals General Information
Description
Jagsonpal Pharmaceuticals Ltd is a pharmaceutical company engaged in the manufacturing and trading of pharmaceutical formulations and active pharmaceutical ingredients (APIs). Its portfolio covers therapeutic areas including Gynaecology, Orthopaedics, Dermatology and Paediatrics, with Gynaecology and Orthopaedics forming its core areas of focus. The company offers a range of pharmaceutical formulations, and its brands include Lycored, Maintane, Doxypal DR, Indocap and others.
Contact Information
Website
www.jagsonpal.comCorporate Office
- Plot No. 412-415, Nimai Tower, 3rd Floor
- Phase IV, Udyog Vihar, Sector-18
- Gurugram, Haryana 122015
- India
Corporate Office
- Plot No. 412-415, Nimai Tower, 3rd Floor
- Phase IV, Udyog Vihar, Sector-18
- Gurugram, Haryana 122015
- India
Jagsonpal Pharmaceuticals Stock Performance
As of 13-Nov-2026, Jagsonpal Pharmaceuticals’s stock price is $2.30. Its current market cap is $152M with 66.1M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $2.30 | $2.32 | $1.69 - $2.79 | $152M | 66.1M | 12.6K | $0.07 |
Jagsonpal Pharmaceuticals Financials Summary
As of 30-Sep-2026, Jagsonpal Pharmaceuticals has a trailing 12-month revenue of $34.1M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2026 31-Mar-2026 | FY 2025 31-Mar-2025 | FY 2024 31-Mar-2024 |
|---|---|---|---|---|
| EV | 152,867 | 114,365 | 159,371 | 76,119 |
| Revenue | 34,055 | 32,505 | 31,779 | 25,210 |
| EBITDA | 7,602 | 6,343 | 8,421 | 2,865 |
| Net Income | 4,874 | 4,876 | 6,547 | 2,713 |
| Total Assets | 33,135 | 33,563 | 32,530 | 26,031 |
| Total Debt | 959 | 865 | 1,080 | 1,072 |
Jagsonpal Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Jagsonpal Pharmaceuticals Comparisons
Industry
Financing
Details
Jagsonpal Pharmaceuticals Competitors (17)
One of Jagsonpal Pharmaceuticals’s 17 competitors is Evonile Pharma, a Private Equity-Backed company based in Mumbai, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Evonile Pharma | Private Equity-Backed | Mumbai, India | ||||
| Dr. Reddy's | Corporation | Hyderabad, India | ||||
| Sun Pharmaceutical Industries | Corporation | Mumbai, India | ||||
| Novartis | Corporation | Basel, Switzerland | ||||
| GSK | Corporation | London, United Kingdom |
Jagsonpal Pharmaceuticals Signals
Jagsonpal Pharmaceuticals Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Jagsonpal Pharmaceuticals Investments & Acquisitions (5)
Jagsonpal Pharmaceuticals’s most recent deal was a Corporate Asset Purchase with Group Pharmaceuticals (Wellness Portfolio) for . The deal was made on 01-Oct-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Group Pharmaceuticals (Wellness Portfolio) | 01-Oct-2026 | Corporate Asset Purchase | Buildings and Property | ||
| Aequitas Healthcare | 07-Jul-2026 | Buyout/LBO | Pharmaceuticals | ||
| Resilient Cosmeceuticals | 21-Feb-2025 | Merger/Acquisition | Pharmaceuticals | ||
| Yash Pharma (India and Bhutan Businesses) | 01-Jun-2024 | Merger/Acquisition | Specialty Retail | ||
| Zingavita | 11-Feb-2021 | Seed Round | Other Consumer Non-Durables |
Jagsonpal Pharmaceuticals ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Jagsonpal Pharmaceuticals Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Aequitas Healthcare | Mumbai, India | 2017 |
Jagsonpal Pharmaceuticals FAQs
-
When was Jagsonpal Pharmaceuticals founded?
Jagsonpal Pharmaceuticals was founded in 1978.
-
Where is Jagsonpal Pharmaceuticals headquartered?
Jagsonpal Pharmaceuticals is headquartered in Gurugram, India.
-
What is the size of Jagsonpal Pharmaceuticals?
Jagsonpal Pharmaceuticals has 1,305 total employees.
-
What industry is Jagsonpal Pharmaceuticals in?
Jagsonpal Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is Jagsonpal Pharmaceuticals a private or public company?
Jagsonpal Pharmaceuticals is a Public company.
-
What is Jagsonpal Pharmaceuticals’s stock symbol?
The ticker symbol for Jagsonpal Pharmaceuticals is 507789.
-
What is the current stock price of Jagsonpal Pharmaceuticals?
As of 13-Nov-2026 the stock price of Jagsonpal Pharmaceuticals is $2.30.
-
What is the current market cap of Jagsonpal Pharmaceuticals?
The current market capitalization of Jagsonpal Pharmaceuticals is $152M.
-
What is Jagsonpal Pharmaceuticals’s current revenue?
The trailing twelve month revenue for Jagsonpal Pharmaceuticals is $34.1M.
-
Who are Jagsonpal Pharmaceuticals’s competitors?
Evonile Pharma, Dr. Reddy's, Sun Pharmaceutical Industries, Novartis, and GSK are some of the 17 competitors of Jagsonpal Pharmaceuticals.
-
What is Jagsonpal Pharmaceuticals’s annual earnings per share (EPS)?
Jagsonpal Pharmaceuticals’s EPS for 12 months was $0.07.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process